Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Grand River Aseptic Manufacturing Has a New Majority Owner | Contract Pharma

What are you searching for?

Sign in
Breaking News

Grand River Aseptic Manufacturing Has a New Majority Owner

The investment will provide funding for GRAM to expand and add capacity to their services

By: Betsy Louda

, Contract Pharma

Grand River Aseptic Manufacturing (GRAM), a provider of parenteral solutions, is now under majority ownership of Arlington Capital Partners, a private equity firm in the Washington, D.C., area. The new partnership will enable GRAM to meet the growing development and commercial demand in many sectors of the injectables market, including biologics and generics.

 

GRAM’s facilities support pharmaceutical development, cGMP manufacturing, analytical testing, and regulatory filing. They were recently named one of the country’s fastest growing private companies, according to INC. 5000, and is Michigan’s ninth fastest growing private company. 

 

“The additional capital and industry knowledge that Arlington provides will aid in sustaining the historical growth rates,” said Tom Ross, chief executive officer of GRAM. “Since we opened our doors in January 2011, the employee count has grown from 16 to over 160 today.”






 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics